Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001949864-24-000014
Filing Date
2024-08-13
Accepted
2024-08-13 16:18:08
Documents
37
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 REPORT maga10k_30apr2024.htm   iXBRL 10-K 313128
2 CERTIFICATION ex31.htm EX-31.1 9513
3 CERTIFICATION ex32.htm EX-32.1 8059
  Complete submission text file 0001949864-24-000014.txt   1632363

Data Files

Seq Description Document Type Size
4 none-20240430.xsd EX-101.SCH 12240
5 none-20240430_cal.xml EX-101.CAL 22956
6 none-20240430_def.xml EX-101.DEF 13879
7 none-20240430_lab.xml EX-101.LAB 111894
8 none-20240430_pre.xml EX-101.PRE 82337
40 EXTRACTED XBRL INSTANCE DOCUMENT maga10k_30apr2024_htm.xml XML 131996
Mailing Address 325 W WASHINGTON ST, STE 2877 SAN DIEGO CA 92103
Business Address 325 W WASHINGTON ST, STE 2877 SAN DIEGO CA 92103 16204692043
Mag Magna Corp. (Filer) CIK: 0001949864 (see all company filings)

EIN.: 981626237 | State of Incorp.: WY | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 333-268561 | Film No.: 241201755
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)